Article Data

  • Views 345
  • Dowloads 117

Case Reports

Open Access

Prolonged survival in two cases of carcinoma of the fallopian tube presenting after hysterectomy: case reports

  • M. Alarab1
  • M. Foley2,*,
  • D. Fennelly3

1Specialist Registrar in Obstetrics and Gynaecology, Ireland

2Consultant Gynaecological Oncologist, Ireland

3Consultant Medical Oncologist, Department of Obstetric and Gynaecology, National Maternity· Hospital, Dublin, Ireland

DOI: 10.12892/ejgo20030191 Vol.24,Issue 1,January 2003 pp.91-92

Published: 10 January 2003

*Corresponding Author(s): M. Foley E-mail:

Abstract

Two patients presented with fallopian tube carcinoma after hysterectomy. Both have had a prolonged survival after surgical debulking and chemotherapy with platinum-based agents.

Keywords

Fallopian tube carcinoma; Hysterectomy; survival

Cite and Share

M. Alarab,M. Foley,D. Fennelly. Prolonged survival in two cases of carcinoma of the fallopian tube presenting after hysterectomy: case reports. European Journal of Gynaecological Oncology. 2003. 24(1);91-92.

References

[1] Muntz H. G., Goff B. A., Thor A. D., Tarraza H. M.: "Post-hysterectomy carcinoma of the fallopian tube mimicking a vesicovaginal fistula". Obstet. Gynaecol., 1992, 79, 853.

[2] Warshal D. P., Burgelson E. R., Aikins J. K., Rocereto T. F.: "Post hysterectomy fallopian tube carcinoma presenting with a positive Papanicolaou smear". Obstet. Gynaecol., 1999, 94, 834.

[3] Klein M., Rosen A., Lahousen M., Graf A., Rainer A.: "The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, Stage 1 and 11: Irradiation vs. chemotherapy". Int. J. Rad. One. Bio. Phys., 2000, 48, 1427.

[4] Morris M., Gershenson D. M., Burke T. W., Kavanagh J. J., Silva E. G., Taylor Warton J.: "Treatment of fallopian tube carcinoma with cisplatin, doxarubucin and cyclophosphamide". Obstet Gynaecol., 1990, 76, 1020.

[5] Barakat R. R., Rubin S. C., Saigo P. E., Lewis J. L., Jones W. B., Curtin J. P.: "Second-look laparotomy in carcinoma of the fallopian tube". Obstet. Gynaecol., 1993, 82, 149.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top